eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

Jacob A. Boyer(Memorial Sloan Kettering Cancer Center), Neal Rosen(Memorial Sloan Kettering Cancer Center)
bioRxiv (Cold Spring Harbor Laboratory)
May 11, 2024
Cited by 2


Related Papers